TREATMENT OUTCOMES OF NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) BY O6-METHYLGUANINE DNA METHYLTRANSFERASE PROMOTER (MGMT) STATUS: A MULTI-COUNTRY STUDY

被引：0
|
作者：
Fu, A. Z. [1 ,2 ]
Hall, J. P. [3 ]
Bailey, A. [3 ]
Kemp, J. [3 ]
Thompson, G. J. [4 ]
Lee, C. [1 ]
机构：
[1] Bristol Myers Squibb, Lawrenceville, NJ USA
[2] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA
[3] Adelphi Real World, Manchester, Lancs, England
[4] Bristol Myers Squibb, Uxbridge, Middx, England
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz126.265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P14.30
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] ANATOMIC LOCALIZATION OF O6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) PROMOTER METHYLATED AND UNMETHYLATED TUMORS: AN ADIFFI STATISTICAL MAPPING STUDY IN 384 DE NOVO GLIOBLASTOMA PATIENTS
    Ellingson, Benjamin M.
    Cloughesy, Timothy F.
    Pope, Whitney B.
    Zaw, Taryar
    Phillips, Heidi
    Lalezari, Shadi
    Nghiemphu, Phioanh L.
    Ibrahim, Hassana
    Motevalibashinaeini, Korosh
    Lai, Albert
    NEURO-ONCOLOGY, 2011, 13 : 137 - 137
  • [32] O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Bartolini, Stefania
    Bacci, Antonella
    Agati, Raffaele
    Ghimenton, Claudio
    Turazzi, Sergio
    Talacchi, Andrea
    Skrap, Miran
    Marucci, Gianluca
    Volpin, Lorenzo
    Morandi, Luca
    Pizzolitto, Stefano
    Gardiman, Marina
    Andreoli, Alvaro
    Calbucci, Fabio
    Ermani, Mario
    NEURO-ONCOLOGY, 2010, 12 (03) : 283 - 288
  • [33] Pharmacokinetics of paxalisib in phase 2 clinical study in glioblastoma (GBM) with unmethylated O6-methylguanine-methyltransferase (MGMT) promotor status.
    Wen, Patrick Y.
    de Groot, John
    Battiste, James D.
    Goldlust, Samuel A.
    Damek, Denise
    Garner, James S.
    Simpson, Jeremy A.
    Olivero, Alan
    Cloughesy, Timothy
    CANCER RESEARCH, 2021, 81 (13)
  • [34] O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is a prognostic factor in anaplastic astrocytomas
    Tosoni, A.
    Franceschi, E.
    Ermani, M.
    Poggi, R.
    La Torre, L.
    Tomasello, C.
    Marucci, G.
    Maestri, A.
    Bartolini, S.
    Brandes, A. A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 500 - 500
  • [35] Association of O6-Methylguanine Methyltransferase (MGMT) Promotor Methylation Status and the Incidence of Hematologic Toxicities after Treatment with Temozolomide
    Cortese, Alyssa
    Lemma, Rakeb
    Wazir, Ali
    Lee, Mijung
    BLOOD, 2021, 138 : 1910 - +
  • [36] Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
    Bush, Zachary M.
    Longtine, Janina A.
    Cunningham, Tracy
    Schiff, David
    Jane, John A., Jr.
    Vance, Mary Lee
    Thorner, Michael O.
    Laws, Edward R., Jr.
    Lopes, M. Beatriz S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (11): : E280 - E290
  • [37] Telomerase reverse transcriptase (TERT) promoter mutation and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation-mediated sensitivity to temozolomide in IDH-wildtype glioblastoma: Is there a link?
    Weller, M.
    Gramatzki, D.
    Felsberg, J.
    Hentschel, B.
    Wolter, M.
    Schackert, G.
    Westphal, M.
    Regli, L.
    Thon, N.
    Tatagiba, M.
    Wick, W.
    Schlegel, U.
    Krex, D.
    Roth, P.
    Rushing, E.
    Pietsch, T.
    von Deimling, A.
    Sabel, M.
    Loeffler, M.
    Reifenberger, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S396 - S396
  • [38] Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas
    Ellingson, Benjamin M.
    Cloughesy, Timothy F.
    Pope, Whitney B.
    Zaw, Taryar M.
    Phillips, Heidi
    Lalezari, Shadi
    Nghiemphu, Phioanh L.
    Ibrahim, Hassana
    Naeini, Kourosh M.
    Harris, Robert J.
    Lai, Albert
    NEUROIMAGE, 2012, 59 (02) : 908 - 916
  • [39] Correlation of commercially available quantitative MGMT (O-6-methylguanine-DNA methyltransferase) promoter methylation scores and GBM patient survival
    Dovek, Laura
    Nguyen, Nhung T.
    Ozer, Byram H.
    Li, Ning
    Elashoff, Robert M.
    Green, Richard M.
    Liau, Linda
    Nghiemphu, P. Leia
    Cloughesy, Timothy F.
    Lai, Albert
    NEURO-ONCOLOGY PRACTICE, 2019, 6 (03) : 194 - 202
  • [40] Cross-talk between the O(6)-Methylguanine-DNA methyltransferase (MGMT) and p53 in glioblastoma multiforme.
    Patyka, Mariia
    Abdulkarim, Bassam
    Xu, Yaoxian
    Sabri, Siham
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345